Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, XBI, ESTA, SLNO, LLY, and represent 44.40% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: LLY (+$78M), LOPE (+$55M), IYR (+$27M), PTON (+$18M), TRML (+$6.6M), EGRX (+$6.6M), CONN, ZYXI, SLN, MLYS.
- Started 21 new stock positions in ALRN, MIST, IYR, EVOK, PERF, STKS, EWTX, RNLX, MLYS, PLCE. LOPE, ARHS, NKTR, NAMS, APRE, LLY, SLN, KPRX, EGRX, ACHV, MTTR.
- Reduced shares in these 10 stocks: XBI (-$130M), ESTA (-$26M), SLNO (-$19M), HGV (-$12M), LXFR (-$12M), RH (-$12M), CYTK (-$9.2M), AMLX (-$9.1M), SPRY (-$8.7M), TARS (-$8.2M).
- Sold out of its positions in Alteryx, AMLX, CDTX, CYTK, DNTH, Eargo Inc - US, Graphite Bio, IDYA, Jasper Therapeutics, MLKN. RH, RFL, SCTL, RNAC, SRTS, SPRY, StarTek, ZM, CHEK.
- Nantahala Capital Management was a net seller of stock by $-81M.
- Nantahala Capital Management has $1.8B in assets under management (AUM), dropping by -47.64%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 118 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 16.2 | $284M | 1.4M | 210.30 |
|
|
| Spdr Ser Tr S&p Biotech (XBI) | 10.5 | $184M | -41% | 1.9M | 94.89 |
|
| Establishment Labs Holdings Ord (ESTA) | 7.3 | $128M | -16% | 2.5M | 50.90 |
|
| Soleno Therapeutics (SLNO) | 5.9 | $103M | -15% | 2.4M | 42.80 |
|
| Eli Lilly & Co. Put Option (LLY) | 4.4 | $78M | NEW | 100k | 777.96 |
|
| Grand Canyon Education Put Option (LOPE) | 3.1 | $55M | NEW | 400k | 136.21 |
|
| Meta Financial (CASH) | 2.9 | $52M | -3% | 1.0M | 50.48 |
|
| Costco Wholesale Corporation Put Option (COST) | 2.9 | $51M | 70k | 732.63 |
|
|
| Evolus (EOLS) | 2.3 | $41M | 2.9M | 14.00 |
|
|
| Peloton Interactive Cl A Com (PTON) | 2.1 | $37M | +96% | 8.7M | 4.29 |
|
| Imax Corp Cad (IMAX) | 2.0 | $36M | -17% | 2.2M | 16.17 |
|
| Hilton Grand Vacations (HGV) | 1.8 | $32M | -27% | 669k | 47.21 |
|
| Bioventus Com Cl A (BVS) | 1.7 | $30M | -2% | 5.8M | 5.20 |
|
| Rumbleon Com Cl B (RMBL) | 1.6 | $29M | 4.4M | 6.46 |
|
|
| Ishares Tr U.s. Real Es Etf Put Option (IYR) | 1.5 | $27M | NEW | 300k | 89.90 |
|
| Red Violet (RDVT) | 1.2 | $22M | -7% | 1.1M | 19.55 |
|
| Abeona Therapeutics Com New (ABEO) | 1.2 | $21M | +2% | 2.8M | 7.25 |
|
| America's Car-Mart (CRMT) | 1.1 | $20M | 312k | 63.87 |
|
|
| Keros Therapeutics (KROS) | 1.1 | $20M | -8% | 294k | 66.20 |
|
| Lyra Therapeutics (LYRA) | 1.0 | $18M | -30% | 2.8M | 6.22 |
|
| Uniqure Nv SHS (QURE) | 1.0 | $17M | +5% | 3.3M | 5.20 |
|
| Tourmaline Bio (TRML) | 0.9 | $16M | +70% | 701k | 22.90 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.9 | $16M | +12% | 2.6M | 6.06 |
|
| Codexis (CDXS) | 0.9 | $16M | -2% | 4.5M | 3.49 |
|
| Viemed Healthcare (VMD) | 0.8 | $15M | -20% | 1.6M | 9.43 |
|
| Dxp Enterprises Com New (DXPE) | 0.8 | $15M | +33% | 270k | 53.73 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.8 | $14M | 1.0M | 14.30 |
|
|
| Zevra Therapeutics Com New (ZVRA) | 0.8 | $14M | 2.5M | 5.80 |
|
|
| Dyne Therapeutics (DYN) | 0.7 | $12M | -32% | 435k | 28.39 |
|
| Reservoir Media (RSVR) | 0.7 | $12M | 1.6M | 7.93 |
|
|
| eHealth (EHTH) | 0.7 | $12M | +53% | 1.9M | 6.03 |
|
| Enova Intl (ENVA) | 0.6 | $11M | 181k | 62.83 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.6 | $11M | -17% | 465k | 23.80 |
|
| Aura Biosciences (AURA) | 0.6 | $10M | 1.3M | 7.85 |
|
|
| Neuropace (NPCE) | 0.6 | $10M | -33% | 778k | 13.20 |
|
| Golden Entmt (GDEN) | 0.6 | $9.9M | -7% | 269k | 36.83 |
|
| Assertio Holdings Com New (ASRT) | 0.5 | $8.9M | +21% | 9.3M | 0.96 |
|
| Payoneer Global (PAYO) | 0.5 | $8.9M | +4% | 1.8M | 4.86 |
|
| Savara (SVRA) | 0.5 | $8.7M | +75% | 1.7M | 4.98 |
|
| Unicycive Therapeutics (UNCY) | 0.5 | $8.6M | -2% | 3.3M | 2.59 |
|
| Rmr Group Cl A (RMR) | 0.5 | $8.3M | -14% | 346k | 24.00 |
|
| Immatics SHS (IMTX) | 0.5 | $8.3M | -44% | 788k | 10.51 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.5 | $8.1M | -5% | 1.9M | 4.29 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.5 | $8.0M | -16% | 1.5M | 5.28 |
|
| Rezolute Com New (RZLT) | 0.4 | $7.7M | +96% | 3.0M | 2.55 |
|
| Noodles & Co Com Cl A (NDLS) | 0.4 | $7.7M | +7% | 4.0M | 1.91 |
|
| Cellectar Biosciences Com New (CLRB) | 0.4 | $7.5M | +38% | 1.9M | 3.98 |
|
| Luxfer Hldgs SHS (LXFR) | 0.4 | $7.1M | -62% | 685k | 10.37 |
|
| NN (NNBR) | 0.4 | $6.7M | 1.4M | 4.74 |
|
|
| Eagle Pharmaceuticals (EGRX) | 0.4 | $6.6M | NEW | 1.3M | 5.24 |
|
| Reading Intl Cl A (RDI) | 0.4 | $6.2M | 3.4M | 1.84 |
|
|
| Tela Bio (TELA) | 0.4 | $6.2M | 1.1M | 5.67 |
|
|
| Zynex (ZYXI) | 0.3 | $6.1M | +308% | 490k | 12.37 |
|
| Conn's (CONN) | 0.3 | $5.9M | +392% | 1.8M | 3.35 |
|
| Tarsus Pharmaceuticals (TARS) | 0.3 | $5.5M | -59% | 150k | 36.35 |
|
| Cogent Biosciences (COGT) | 0.3 | $5.3M | +23% | 791k | 6.72 |
|
| Alta Equipment Group Common Stock (ALTG) | 0.3 | $5.2M | +33% | 403k | 12.95 |
|
| Elutia Cl A Com (ELUT) | 0.3 | $5.2M | 1.7M | 3.15 |
|
|
| Playags (AGS) | 0.3 | $5.1M | 567k | 8.98 |
|
|
| Herbalife Com Shs Call Option (HLF) | 0.3 | $5.0M | -16% | 500k | 10.05 |
|
| Dhi (DHX) | 0.3 | $5.0M | -25% | 2.0M | 2.55 |
|
| Inspiremd (NSPR) | 0.3 | $4.9M | 2.1M | 2.37 |
|
|
| Par Technology Corp Note 2.875% 4/1 (Principal) | 0.3 | $4.7M | 3.8M | 1.25 |
|
|
| Xtant Med Hldgs Com New (XTNT) | 0.3 | $4.7M | 4.0M | 1.17 |
|
|
| Theratechnologies Com New (THTX) | 0.3 | $4.5M | 2.7M | 1.66 |
|
|
| Silence Therapeutics Ads (SLN) | 0.2 | $4.3M | NEW | 200k | 21.60 |
|
| Mineralys Therapeutics (MLYS) | 0.2 | $4.3M | NEW | 333k | 12.91 |
|
| Vanda Pharmaceuticals (VNDA) | 0.2 | $4.2M | 1.0M | 4.11 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $4.1M | NEW | 175k | 23.65 |
|
| Dariohealth Corp Com New (DRIO) | 0.2 | $4.0M | +12% | 2.6M | 1.53 |
|
| Neurogene (NGNE) | 0.2 | $3.7M | 72k | 50.90 |
|
|
| Optinose (OPTN) | 0.2 | $3.6M | -21% | 2.5M | 1.46 |
|
| Aytu Biopharma (AYTU) | 0.2 | $3.3M | 1.1M | 3.04 |
|
|
| Milestone Pharmaceuticals (MIST) | 0.2 | $3.1M | NEW | 1.8M | 1.79 |
|
| One Group Hospitality In (STKS) | 0.2 | $3.1M | NEW | 548k | 5.57 |
|
| Mediaalpha Cl A (MAX) | 0.2 | $3.0M | -17% | 149k | 20.37 |
|
| Achieve Life Sciences (ACHV) | 0.2 | $3.0M | NEW | 654k | 4.54 |
|
| Gaia Cl A (GAIA) | 0.2 | $2.8M | 915k | 3.08 |
|
|
| Envveno Medical (NVNO) | 0.2 | $2.7M | -29% | 496k | 5.44 |
|
| Aerovate Therapeutics (AVTE) | 0.2 | $2.7M | 91k | 29.57 |
|
|
| Nektar Therapeutics (NKTR) | 0.1 | $2.3M | NEW | 2.5M | 0.93 |
|
| Altisource Portfolio Solns S Reg Shs (ASPS) | 0.1 | $2.1M | +2% | 1.1M | 1.94 |
|
| Talphera Com New (TLPH) | 0.1 | $2.1M | 2.0M | 1.03 |
|
|
| Aileron Therapeutics Com New (ALRN) | 0.1 | $1.7M | NEW | 255k | 6.63 |
|
| Immatics *w Exp 07/01/202 (IMTXW) | 0.1 | $1.5M | 559k | 2.70 |
|
|
| Scully Royalty Com Shs (SRL) | 0.1 | $1.5M | 239k | 6.15 |
|
|
| Anebulo Pharmaceuticals (ANEB) | 0.1 | $1.5M | 511k | 2.87 |
|
|
| Neuroone Med Technologies Com New (NMTC) | 0.1 | $1.4M | 1.2M | 1.20 |
|
|
| Perella Weinberg Partners Class A Com (PWP) | 0.1 | $1.4M | -35% | 100k | 14.13 |
|
| Aprea Therapeutics Com New (APRE) | 0.1 | $1.4M | NEW | 206k | 6.69 |
|
| Instil Bio Com New (TIL) | 0.1 | $1.4M | 127k | 10.80 |
|
|
| Kiora Pharmaceuticals Com New (KPRX) | 0.1 | $1.3M | NEW | 1.9M | 0.71 |
|
| Fossil (FOSL) | 0.1 | $1.3M | +222% | 1.3M | 1.02 |
|
| B. Riley Financial (RILY) | 0.1 | $1.3M | 63k | 21.17 |
|
|
| Matterport Com Cl A (MTTR) | 0.1 | $1.2M | NEW | 548k | 2.26 |
|
| Strata Skin Sciences Com New (SSKN) | 0.1 | $1.2M | 3.1M | 0.38 |
|
|
| Children's Place Retail Stores (PLCE) | 0.1 | $1.2M | NEW | 100k | 11.54 |
|
| Spar (SGRP) | 0.1 | $897k | 879k | 1.02 |
|
|
| Cutera Note 4.000% 6/0 (Principal) | 0.1 | $888k | 4.0M | 0.22 |
|
|
| Gossamer Bio (GOSS) | 0.0 | $794k | 673k | 1.18 |
|
|
| Fortress Biotech Com New (FBIO) | 0.0 | $556k | -25% | 278k | 2.00 |
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $496k | NEW | 200k | 2.48 |
|
| Evoke Pharma Com New (EVOK) | 0.0 | $412k | NEW | 675k | 0.61 |
|
| An2 Therapeutics (ANTX) | 0.0 | $319k | -60% | 98k | 3.25 |
|
| Ladder Cap Corp Cl A (LADR) | 0.0 | $285k | 26k | 11.13 |
|
|
| Edgewise Therapeutics (EWTX) | 0.0 | $244k | NEW | 13k | 18.24 |
|
| Aptose Biosciences (APTO) | 0.0 | $147k | -26% | 89k | 1.66 |
|
| Lucid Diagnostics (LUCD) | 0.0 | $132k | 150k | 0.88 |
|
|
| Bm Technologies Cl A Com (BMTX) | 0.0 | $126k | 76k | 1.65 |
|
|
| TransAct Technologies Incorporated (TACT) | 0.0 | $125k | -14% | 24k | 5.24 |
|
| Exagen (XGN) | 0.0 | $118k | -23% | 74k | 1.59 |
|
| Renalytix Ads (RNLX) | 0.0 | $101k | NEW | 118k | 0.86 |
|
| Cue Biopharma (CUE) | 0.0 | $50k | 27k | 1.89 |
|
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $50k | 154k | 0.33 |
|
|
| Gamida Cell SHS (GMDA) | 0.0 | $29k | 800k | 0.04 |
|
|
| Tc Biopharm Holdings *w Exp 02/10/202 (TCBPW) | 0.0 | $4.7k | 235k | 0.02 |
|
|
| Kintara Therapeutics Com New (KTRA) | 0.0 | $1.3k | -42% | 13k | 0.10 |
|
| Arhaus Com Cl A (ARHS) | 0.0 | $15.000000 | NEW | 1.00 | 15.00 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023
- Nantahala Capital Management 2023 Q1 filed May 15, 2023
- Nantahala Capital Management 2022 Q4 filed Feb. 14, 2023
- Nantahala Capital Management 2022 Q3 filed Nov. 10, 2022
- Nantahala Capital Management 2022 Q2 filed Aug. 15, 2022
- Nantahala Capital Management 2022 Q1 filed May 13, 2022
- Nantahala Capital Management 2021 Q4 filed Feb. 14, 2022
- Nantahala Capital Management 2021 Q3 filed Nov. 15, 2021
- Nantahala Capital Management 2021 Q2 filed Aug. 16, 2021
- Nantahala Capital Management 2021 Q1 filed May 14, 2021
- Nantahala Capital Management 2020 Q4 filed Feb. 16, 2021
- Nantahala Capital Management 2020 Q3 filed Nov. 16, 2020